M&A
M&A
Deals continued to surge in Summer months
In health care—and across the Globe—M&A activity continued at a frenzy in the Summer months. Notable deals from the last three months included the mergers between Baxter and Hill-Rom, Intermountain Healthcare and SCL Health, Ginger and Headspace, and more.
Read More
M&A
Video: Policy insiders discuss health care consolidation and change management
At the Health Evolution Summit, federal and state policy leaders went into depth about what kind of impact increased M&A activity in health care might have on care coordination.
Read More
Leadership
Update: The benefits of participating in the Health Evolution Virtual Summit 2021
The in-person Summit is sold out, but virtual registrants can access all Main Stage programming featuring more than 30 CEOs leading large health systems, health plans and life sciences organizations as well as the Brass Tacks breakout discussions and networking opportunities with other Summit participants.
Read More
Leadership
Top 10 articles of 2021 – so far
From difficult conversations about racism and the experience of trauma to digital health funding to alternative and disruptive payment models, the first half of this year saw critical developments in executives thinking, practices and strategies.
Read More
M&A
Health care M&A report: The deals are coming fast and furious
Reviewing some of the major mergers and acquisitions that occurred from March to June, in general the spring months saw numerous high-value deals across the provider, life sciences and health tech sectors.
Read More
M&A
Is the FTC increasing scrutiny amid high M&A levels in health care?
Unprecedented levels of M&A activity are underway and expected to continue in 2021—if the FTC doesn’t step in to block some deals. Here’s what CEOs can expect from FTC enforcement in the Biden administration.
Read More
Consumerism
Deals Report: Early pharma M&A activity points to a busy 2021
Despite the hefty AstraZeneca-Alexion deal, 2020 was considered a slow year in terms of mergers and acquisitions in life sciences. Early activity in the winter signals that 2021 may be a different story.
Read More
Affordability
As investments into ASCs soar, health care leaders must navigate a new landscape
Investing in ASCs is all the rage for health care organizations, according to recent survey data. But enterprises moving into the space must understand it’s not a walk in the park or an easy revenue stream.
Read More
M&A
Deals Report: Examining recent M&A activity in health care
As 2020 comes to an end, M&A activity in the health care sector will see an overall decline in deal volume and value. But while the pandemic has negatively impacted M&A, it hasn’t slowed down activity entirely. Here are some recent deals.
Read More
M&A
Summer Deals Report: Looking at M&A in health care from June to August
In the initial installment of our deals report, Health Evolution looks at the proposed and finalized mergers and acquisitions in the industry that occurred over the preceding three months.
Read MoreInsights
